Literature DB >> 6751647

Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs.

C K Christensen, O Lederballe Pedersen, E Mikkelsen.   

Abstract

The effects on blood pressure and renal function of a single 20-mg sublingual dose of nifedipine were investigated in 10 patients with mild to moderate arterial hypertension insufficiently treated on beta-blocker monotherapy. Nifedipine induced a prompt and marked reduction of both systolic and diastolic blood pressure (average maximal reduction 30/22 mm Hg, P less than 0.001). Despite the beta blockade, heart rate rose 25%. Only insignificant increments of glomerular filtration (RVR) was markedly reduced (P less than 0.001). Urinary excretion rate of albumin and beta-2 microglobulin rose after nifedipine, reflecting changes in glomerular as well as tubular function. Mean blood pressure seemed to be a major determinant of the excretion of proteins. There was a marked increase in the excretion of sodium after nifedipine and urine volume rose from a mean of 8.2 +/- 1.3 to 12.5 +/- 1.8 ml/min (P less than 0.01). The changes in sodium excretion rate correlated with the renal hemodynamic changes. Uric acid excretion rate rose remarkably after nifedipine and the magnitude of the changes seemed intimately related to the basal level of RVR. The results indicate that nifedipine therapy may be advantageous in patients whose hypertension is insufficiently controlled with beta blockers alone. Renal blood flow is maintained and there is a desirable diuretic action and enhancement of uric acid excretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751647     DOI: 10.1038/clpt.1982.205

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Microalbuminuria in systemic sclerosis.

Authors:  A Dawnay; A G Wilson; E Lamb; J D Kirby; W R Cattell
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine.

Authors:  M D Ene; P J Williamson; C J Roberts; G Waddell
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

4.  Antihypertensive and biochemical effects of the dihydropyridine felodipine in the long term treatment of moderate to severe hypertension.

Authors:  H E Sluiter; F T Huysman; T A Thien; R A Koene
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Renal uric acid handling is not affected by beta-adrenoceptor blockade in normotensive subjects.

Authors:  O L Pedersen; F K Jacobsen; K Stengaard-Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.

Authors:  H E Sluiter; F T Huysmans; T A Thien; H J van Lier; R A Koene
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 7.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

8.  Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls--a proximal tubular effect?

Authors:  L R Krusell; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.

Authors:  D Maclean; E T Mitchell; R R Coulson; T J Fitzsimons; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

10.  Acute renal effects of oral felodipine in normal man.

Authors:  A Schmitz
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.